Drug Discovery Technology Alert. Targeting Outer Mitochondrial Membrane Protein Activity for Improving Type II Diabetes Therapeutics; Triple Layer Microsphere for Effective Drug Delivery and Retention for Duodenum
This issue profiles targeting outer mitochondrial membrane protein activity for improving type II diabetes therapeutics, a triple layer microsphere for effective drug delivery and retention for duodenum, and a small molecule that can prevent type I diabetes.
Click headings to expand and collapse
Published: 18 Nov 2011
Tools
Features of this research
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..
